当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2007年第35期
编号:11517715
树突状细胞体外培养体系的优化(3)
http://www.100md.com 2008年1月19日 王佳烈 马国强 高维实 刘艳茹
第1页

    参见附件(371KB,3页)。

     [2]Jonuleit H,Adema G, Schmitt E. Dendritic cells : specialized and regulated antigen processing machines[J].Gin Invest, 2001,106(3):255-258.

    [3]Homma S,Toda G, Gong J, et al. Preventive anti-tumor activity against hepatocellular carcinoma(HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice[J]. Gastroentero1, 2004 ,36:764-771.

    [4]Um HD, Cho YH, Kim DK, et al. TNF-alpha suppresses dendritic cell death and the production of reactiveoxygen intermediates induced by plasma withdrawal[J]. J Exp Med, 2006, 13(5 ): 282-288.

    [5]Reider D, Heuer M. The dendritic cell and human cancer vaccines[J]. Scand J Immunol, 2005,12(5):583-588.

    [6]周清,吴一龙,郭爱林,等.无血清专用培养基体外快速培养临床级树突状细胞的实验探讨[J].中国肿瘤临床,2006,11(33):605-613.

    [7]Peng JC, Thomas R, Nielsen LK, et al. Human cell culture, primary hematopoietic cells[J]. Nat Med,2006, 36(11):121-123.

    [8]Kreisel LD, Faries MB. Monocyte-derived dendritic cells: development of a cellular processor for clinical applications[J]. Annu Rev Immunol,2004,149(16):643-646.

    (收稿日期:2007-11-02)

    “本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文”

您现在查看是摘要介绍页,详见PDF附件(371KB,3页)